[Prenatal diagnosis and management of fetuses with congenital diaphragmatic hernia]

I Urbánková1, L Haaková, Z Stranák

  • 1Ustav pro péci o matku a díte 3. LF UK.

Ceska Gynekologie
|February 9, 2012
PubMed

Insights

Prenatal diagnosis of congenital diaphragmatic hernia (CDH) relies on ultrasound, measuring lung-to-head ratio (LHR) and assessing liver position. Early referral to specialized centers is crucial for effective CDH management.

Area of Science:

  • Medical Imaging
  • Fetal Medicine
  • Neonatal Surgery

Background:

  • Congenital diaphragmatic hernia (CDH) is a serious birth defect.
  • Accurate prenatal diagnosis is essential for optimal fetal management.
  • The Institute for the Care of Mother and Child reviews current diagnostic and management strategies.

Purpose of the Study:

  • To review current prenatal diagnostic methods for fetal CDH.
  • To outline management options for fetuses diagnosed with CDH.
  • To emphasize the importance of specialized care centers.

Main Methods:

  • Literature review on prenatal diagnosis and management of CDH.
  • Utilizing 2D ultrasound for diagnosis.
  • Incorporating 3D ultrasonography and MRI for supplementary assessment.

Main Results:

  • Prenatal diagnosis of CDH is primarily based on 2D ultrasound.
  • Key prognostic indicators include lung-to-head ratio (LHR), O/E LHR, defect location, liver position, and associated anomalies.
  • Advanced imaging like 3D ultrasound and MRI can supplement diagnosis.

Conclusions:

  • Accurate prenatal assessment of CDH is achievable through various imaging techniques.
  • Identifying negative prognostic factors aids in predicting outcomes.
  • Referral to specialized centers is a critical component of successful CDH management.
Abstract

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations: